One well-described pharmacogenetic association is that between the solute carrier organic anion transporter family member 1B1 (SLCO1B1) gene and statin-associated muscle symptoms (SAMS). Here, SLCO1B1 is linked to short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome.